Uso previo de antagonistas de la angiotensina II en pacientes hipertensos hospitalizados y mortalidad por COVID-19

Keyphrases

• Hypertensive Patients 100%
• Angiotensin Receptor Blockers 100%
• COVID-19 Mortality 100%
• COVID-19 50%
• Angiotensin II Antagonist 50%
• Peru 25%
• Lima 25%
• Fibrinogen 25%
• No Significant Difference 25%
• Lactate Dehydrogenase 25%
• Non-associated 25%
• Serum Levels 25%
• Ferritin 25%
• Mortality Risk 25%
• Leukocyte Count 25%
• Tertiary Care Hospital 25%
• C-reactive Protein 25%
• Charlson Comorbidity Index 25%
• Severe COVID-19 25%
• D-dimer 25%
• Hospitalized COVID-19 Patients 25%
• Retrospective Observational Study 25%
• Patients with Hypertension 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin Receptor Antagonist 100%
• Angiotensin II Antagonist 100%
• Infection 50%
• Fibrinogen 50%
• Lactate Dehydrogenase 50%
• Comorbidity 50%
• Observational Study 50%
• C Reactive Protein 50%
• D Dimer 50%
• Ferritin 50%

Neuroscience

• Angiotensin Receptor 100%
• Angiotensin II 100%
• Fibrinogen 50%
• Lactate Dehydrogenase 50%
• D Dimer 50%
• Ferritin 50%
• C-Reactive Protein 50%
• Leukocyte 50%